#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Ewing's sarcoma recurrent Crigler-Najjar syndrome Small cell lung cancer recurrent Vernal keratoconjunctivitis Colon cancer Langerhans' cell histiocytosis Malignant melanoma Thalassaemia beta Metachromatic leukodystrophy Pericarditis Biliary cancer metastatic Oesophageal adenocarcinoma stage II Precursor T-lymphoblastic lymphoma/leukaemia recurrent Brain abscess More trials…

    Learn about Rare Diseases

    Skin angiosarcoma Progressive multifocal leukoencephalopathy – Trials in Disease Gastrointestinal stromal tumour – Trials in Disease Metachromatic leukodystrophy – Trials in Disease Pleomorphic leiomyosarcoma Mantle cell lymphoma stage II Encephalitis autoimmune – Trials in Disease Crigler-Najjar syndrome – Treatment Mucous membrane pemphigoid Angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Lactate Solution Ergocalciferol Corline Heparin Conjugate Nicotinamide Bp Mps-214 XYLOMETAZOLINE HYDROCHLORIDE Dl-Alpha-Tocopherol Bms-986315 TX000045 VGA039 Entrectinib Piperacillin Asp1570 Fexofenadine Hydrochloride XELAFASLATIDE Aciclovir SODIUM FUSIDATE D5-Ethyl-Beta-D-Glucuronide Sodium Acetate Trihydrate Ads-013 More therapies…

    Learn about Your Condition

    Intestinal infarction Plasma cell myeloma Metastases to peritoneum Huntington's disease Hyperparathyroidism secondary Colitis Takayasu's arteritis Desmoid tumour Hidradenitis Cushing's syndrome Dermatitis Patent ductus arteriosus Nasal sinus cancer Cytomegalovirus infection Neurotrophic keratopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Rosuvastatin Effects on Coronary Artery Plaque Volume in Patients with Stable Chest Pain Using CT Imaging

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Dyslipidaemia
    • Coronary artery disease
    Investigated Drugs:
    • Rosuvastatin
    Hungary

  • Study of oral TherO2-01S22 with anti-HER2 therapy in patients with metastatic breast cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Docetaxel
    • Pertuzumab
    France

  • Study of ADRC001 (Adipose-Derived Stem Cells) for treating dry mouth (xerostomia) in patients who received radiation therapy for head and neck cancer

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dry mouth
    Investigated Drugs:
    • Adrc001
    Denmark

  • Study of cabergoline compared to dienogest and ethinylestradiol for reducing endometriosis symptoms and lesion size in women with confirmed endometriosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Cabergoline
    • Ethinylestradiol
    Spain

  • Evaluation of triptorelin, estradiol, and testosterone compared to placebo for changes in bone markers in postmenopausal women

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Menopause
    Investigated Drugs:
    • Testosterone
    • Triptorelin
    • Estradiol Hemihydrate
    Denmark

  • Study of Azithromycin Effects on Cellular Aging Markers in Healthy Adult Volunteers

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Azithromycin
    Italy
Previous Page
1 … 780 781 782 783 784 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!